ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 609,15
-0,69%
Dow Jones
39 127,80
0,04%
DAX
18 155,24
-0,04%
Brent Oil
84,46
0,33%
Bitcoin
60 993,50
-1,32%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Conatus Pharmaceuticals Inc (CNAT)

  7. Conatus Pharmaceuticals Inc (CNAT) Actualités

CNAT

Conatus Pharmaceuticals (CNAT)

Conatus Pharmaceuticals Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:CNAT
DateHeureSourceTitreSymboleSociété
05/06/202022h03Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CNATConatus Pharmaceuticals Inc
29/05/202022h11Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CNATConatus Pharmaceuticals Inc
29/05/202022h10Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:CNATConatus Pharmaceuticals Inc
18/05/202022h11Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:CNATConatus Pharmaceuticals Inc
18/05/202014h00GlobeNewswire Inc.Leading Independent Proxy Advisory Firms Recommend Conatus Pharmaceuticals Shareholders Vote in Favor of its Merger with Hist...NASDAQ:CNATConatus Pharmaceuticals Inc
14/05/202014h00GlobeNewswire Inc.Histogen Publishes Preclinical Data on its HST 004 Spinal Disc ProgramNASDAQ:CNATConatus Pharmaceuticals Inc
11/05/202014h00GlobeNewswire Inc.Histogen Receives US FDA IND Approval to Initiate Phase 1b/2a Trial of HST 001 in Androgenic AlopeciaNASDAQ:CNATConatus Pharmaceuticals Inc
07/05/202022h05GlobeNewswire Inc.The Conatus Pharmaceuticals Special Meeting of Stockholders Seeking Approval for Proposed Merger with Histogen Inc. will Reco...NASDAQ:CNATConatus Pharmaceuticals Inc
01/05/202022h32Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:CNATConatus Pharmaceuticals Inc
01/05/202022h05GlobeNewswire Inc.Conatus Pharmaceuticals Reports First Quarter 2020 Financial Results and Strategic Process UpdateNASDAQ:CNATConatus Pharmaceuticals Inc
20/04/202014h00GlobeNewswire Inc.Histogen Announces Investigational Device Exemption Application for HST 002NASDAQ:CNATConatus Pharmaceuticals Inc
15/04/202014h00GlobeNewswire Inc.Histogen Publishes New Preclinical Data on its HST 003 Orthopedic ProgramNASDAQ:CNATConatus Pharmaceuticals Inc
06/04/202014h00GlobeNewswire Inc.Histogen Announces Investigational New Drug Application Amendment for HST 001NASDAQ:CNATConatus Pharmaceuticals Inc
02/04/202012h01Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:CNATConatus Pharmaceuticals Inc
01/04/202022h48Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:CNATConatus Pharmaceuticals Inc
30/03/202023h03Edgar (US Regulatory)Registration Statement for Securities to Be Issued in Business Combination Transactions (s-4/a)NASDAQ:CNATConatus Pharmaceuticals Inc
11/03/202022h02Edgar (US Regulatory)Annual Report (10-k)NASDAQ:CNATConatus Pharmaceuticals Inc
11/03/202021h45GlobeNewswire Inc.Conatus Pharmaceuticals Reports 2019 Financial Results and Strategic Process UpdateNASDAQ:CNATConatus Pharmaceuticals Inc
07/02/202023h09Edgar (US Regulatory)Securities Registration: Business Combination (s-4)NASDAQ:CNATConatus Pharmaceuticals Inc
06/02/202014h00PR Newswire (US)Histogen to Present at BIO CEO & Investor ConferenceNASDAQ:CNATConatus Pharmaceuticals Inc
05/02/202020h11Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:CNATConatus Pharmaceuticals Inc
30/01/202014h00PR Newswire (US)Histogen and Allergan Expand Cell Conditioned Media (CCM) Skin Care PartnershipNASDAQ:CNATConatus Pharmaceuticals Inc
28/01/202022h05GlobeNewswire Inc.Conatus Pharmaceuticals and Histogen Enter into Definitive Merger AgreementNASDAQ:CNATConatus Pharmaceuticals Inc
18/11/201922h05GlobeNewswire Inc.Conatus Pharmaceuticals Appoints Kathy Scott as Independent Board MemberNASDAQ:CNATConatus Pharmaceuticals Inc
05/11/201922h05GlobeNewswire Inc.Conatus Pharmaceuticals Reports Third Quarter 2019 Financial ResultsNASDAQ:CNATConatus Pharmaceuticals Inc
06/08/201922h05GlobeNewswire Inc.Conatus Pharmaceuticals Reports Second Quarter 2019 Financial Results and Program UpdatesNASDAQ:CNATConatus Pharmaceuticals Inc
24/06/201922h06GlobeNewswire Inc.Conatus to Explore Strategic Alternatives and Implement Restructuring PlanNASDAQ:CNATConatus Pharmaceuticals Inc
24/06/201922h05GlobeNewswire Inc.Conatus Announces Results from ENCORE-LF and ENCORE-PH Phase 2b Clinical Trials in NASH CirrhosisNASDAQ:CNATConatus Pharmaceuticals Inc
02/05/201922h05GlobeNewswire Inc.Conatus Pharmaceuticals Reports First Quarter 2019 Financial Results and Program UpdatesNASDAQ:CNATConatus Pharmaceuticals Inc
30/04/201913h30GlobeNewswire Inc.Conatus Pharmaceuticals Announces Publication Demonstrating that Emricasan Ameliorates Portal Hypertension, Improves Liver St...NASDAQ:CNATConatus Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:CNAT

Dernières Valeurs Consultées

TG
0HNB
Anheuser Busch InBev Wor...
DGFX
ETHWETH
Ethereum PoW
BIT
I09538
IT0005561540 20250915 13...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés